Cargando…
Role of miR-10b in breast cancer metastasis
Ninety percent of cancer-related mortality is caused by metastasis. Current cancer treatments can control many primary tumors but rarely stop the metastatic spread. Accumulating evidence demonstrates that miRNAs are involved in cancer initiation and progression. Furthermore, several miRNAs have been...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096969/ https://www.ncbi.nlm.nih.gov/pubmed/21067538 http://dx.doi.org/10.1186/bcr2720 |
_version_ | 1782203772912533504 |
---|---|
author | Ma, Li |
author_facet | Ma, Li |
author_sort | Ma, Li |
collection | PubMed |
description | Ninety percent of cancer-related mortality is caused by metastasis. Current cancer treatments can control many primary tumors but rarely stop the metastatic spread. Accumulating evidence demonstrates that miRNAs are involved in cancer initiation and progression. Furthermore, several miRNAs have been found to regulate metastasis. In particular, recent studies provide the first functional evidence that overexpression of a specific miRNA, miR-10b, can contribute to the development of metastasis, which can be exploited therapeutically in treating breast cancer metastasis in mice. Further in-depth analysis should provide more precise evaluation of the roles, mechanisms, and therapeutic utility of this miRNA in breast cancer. |
format | Text |
id | pubmed-3096969 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30969692011-05-18 Role of miR-10b in breast cancer metastasis Ma, Li Breast Cancer Res Review Ninety percent of cancer-related mortality is caused by metastasis. Current cancer treatments can control many primary tumors but rarely stop the metastatic spread. Accumulating evidence demonstrates that miRNAs are involved in cancer initiation and progression. Furthermore, several miRNAs have been found to regulate metastasis. In particular, recent studies provide the first functional evidence that overexpression of a specific miRNA, miR-10b, can contribute to the development of metastasis, which can be exploited therapeutically in treating breast cancer metastasis in mice. Further in-depth analysis should provide more precise evaluation of the roles, mechanisms, and therapeutic utility of this miRNA in breast cancer. BioMed Central 2010 2010-10-26 /pmc/articles/PMC3096969/ /pubmed/21067538 http://dx.doi.org/10.1186/bcr2720 Text en Copyright ©2010 BioMed Central Ltd |
spellingShingle | Review Ma, Li Role of miR-10b in breast cancer metastasis |
title | Role of miR-10b in breast cancer metastasis |
title_full | Role of miR-10b in breast cancer metastasis |
title_fullStr | Role of miR-10b in breast cancer metastasis |
title_full_unstemmed | Role of miR-10b in breast cancer metastasis |
title_short | Role of miR-10b in breast cancer metastasis |
title_sort | role of mir-10b in breast cancer metastasis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096969/ https://www.ncbi.nlm.nih.gov/pubmed/21067538 http://dx.doi.org/10.1186/bcr2720 |
work_keys_str_mv | AT mali roleofmir10binbreastcancermetastasis |